Status:
COMPLETED
Bringing Education Through Technology, Empathic Listening, and Research
Lead Sponsor:
Virginia Commonwealth University
Conditions:
Pregnancy Related
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test a new educational technology-based program and brochure as a supplement to prenatal education from providers. The program provides education about common challenge...
Eligibility Criteria
Inclusion
- Female
- ≥18 years of age
- Meet criteria for Opioid Use Disorder
- Currently receiving MOUD pharmacotherapy (including buprenorphine, buprenorphine/naloxone, or methadone)
- Pregnant (\<34 weeks EGA)
- Initial in-person visit at OB MOTIVATE clinic for the current pregnancy ≤10 weeks ago
Exclusion
- Considering/planning adoption
- Present with a serious cognitive/psychiatric impairment
- Existing language barriers making true informed consent impossible
Key Trial Info
Start Date :
February 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 22 2024
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT05214118
Start Date
February 2 2022
End Date
January 22 2024
Last Update
July 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virginia Commonwealth University
Richmond, Virginia, United States, 23298